About Elastrin
Elastrin is a company based in Simpsonville (United States) founded in 2017. Elastrin has raised $17.25 million across 7 funding rounds from investors including LIfT Biosciences, HHS and SCRA. Elastrin offers products and services including Cardiovascular Therapies. Elastrin operates in a competitive market with competitors including Moderna, Sana Biotechnology, Semma Therapeutics, Adocia and Rezolute, among others.
- Headquarter Simpsonville, United States
- SectorsHealthcare
- Email••••••••
- Website elastrin.com
- Social LinkedIn X
- Legal Name Elastrin Therapeutics Inc.
- Total Equity Funding$17.25M (USD)
in 7 rounds
- Latest Funding Round$500K (USD), Series A
Sep 2024
- InvestorsLIfT Biosciences
& 3 more
Products & Services of Elastrin
Elastrin offers a comprehensive portfolio of products and services, including Cardiovascular Therapies.
Develops treatments targeting root causes of cardiovascular diseases through research
Funding Insights of Elastrin
Elastrin has successfully raised a total of $17.25M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $500 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17.25M
- Total Rounds 7
- Last Round Series A — $500,000
- First Round $25,000
(Nov 2018)
- Investors Count 4
All 7 funding rounds of Elastrin with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
4 investors in total: 4 institutional.
Investors in Elastrin
Elastrin has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include LIfT Biosciences, HHS and SCRA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed and early-stage German tech and biotech investments are conducted. | – | kizoo.com | Karlsruhe, Germany | |
Startups are accelerated across sectors by SCRA. | 1983 | scra.org | United States | |
Neutrophil-based cell therapies for solid tumors are developed. | 2016 | liftbiosciences.com | London, United Kingdom | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Elastrin
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Elastrin
13 people are tracked at Elastrin (2 in leadership, 8 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Douglas Mulhall | Co-founder | Leadership |
Mirko Stange | Co-founder | Leadership |
Michael Burnet | Advisor | Board & advisors |
Patrick Burgermeister | Board Member | Board & advisors |
Christopher G. Carsten | Advisor | Board & advisors |
Juergen J Timmermann | Advisor | Board & advisors |
Marc Trömel | Advisor | Board & advisors |
Yossef Av-Gay | Advisor | Board & advisors |
Sascha Theissen | Advisor | Board & advisors |
Hans Ulrich Von Sobbe | Advisor | Board & advisors |
Naren Vyavahare | CSO | Team |
Valentin Busch | Operational Lead | Team |
Bridgette A. Moffitt | Research Scientist | Team |
Complete people profiles for Elastrin
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Elastrin
3 dated milestones of Elastrin across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Elastrin is founded.
- Funding First funding round of $25K.
- Funding Latest funding round, Series A, of $500K.
Competitors of Elastrin
Elastrin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Sana Biotechnology, Semma Therapeutics, Adocia and Rezolute, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| sana.com | 2018 | Seattle, United States | $821M | 328 | Genetically engineered cell therapies are developed for multiple disorders. | |
| semma-tx.com | 2015 | Cambridge, United States | $158M | 58 | Provider of bio-artificial pancreas for Type 1 Diabetes treatment | |
| adocia.com | 2005 | Lyon, France | $26M | – | Therapeutics for diabetes and obesity treatment are developed. | |
| rezolutebio.com | 2012 | Denver, United States | – | 51 | Therapies for metabolic and orphan diseases are developed by Rezolute. | |
| cellinobio.com | 2017 | Cambridge, United States | $125M | 63 | Developer of autologous cell therapies | |
| pendulumlife.com | 2012 | San Francisco, United States | $109.5M | 55 | Pendulum is focused on developing advanced probiotic solutions. | |
| viacyte.com | 1999 | San Diego, United States | $389.03M | 126 | Cell therapy for diabetes is developed from stem cells. |
Detailed competitors of Elastrin
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elastrin
Complete news archive for Elastrin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Elastrin
10 companies that operate in the same segment as Elastrin (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 245.2 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Elastrin
Elastrin was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Elastrin is headquartered in Simpsonville, United States. It is registered at Simpsonville, South Carolina, United States.
Elastrin is a funded company, having raised a total of $17.25M across 7 funding rounds to date. The company's 1st funding round was a Grant of $25K, raised on Nov 2018.
Elastrin was founded in 2017 in Simpsonville, United States, within the biotechnology sector focused on cardiovascular and respiratory therapeutics. A proprietary platform is utilized to identify and restore degraded elastin in arteries and lungs by eliminating harmful calcification that contributes to vessel thickening. Drug targets are managed through this approach, supporting treatments for related diseases. Operations center on research and development of these therapeutic solutions.
Elastrin's top competitors include Moderna, Sana Biotechnology and Semma Therapeutics.
Elastrin offers Cardiovascular Therapies.
Elastrin has 4 investors. Key investors include LIfT Biosciences, HHS, SCRA, and Kizoo.
Elastrin operates through Elastrin Therapeutics Inc..